United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Technology Industry News Dragoneer to take event technology provider Cvent public in $5.3bn deal Cvent, an enterprise event technology provider, is set to go public through a $5.3 billion merger deal with… byPallavi MadhirajuJuly 23, 2021
